The Food and Drug Administration (FDA) has approved for evaluating in people a nanoparticle-based imaging agent jointly developed at Washington University School of Medicine in St. Louis and …
http://www.physnews.com/bio-medicine-news/cluster1127204343/
Nanoparticle that lights up artery-clogging plaque to be evaluated in clinical trial
28 enero 2015
Volver